Impetus Digital

AUGUST 2, 2024

In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal side effects. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

Medico Reach

FEBRUARY 8, 2023

With the use of trailblazing digital platforms, cost-effective technologies, big data analytics, blockchain, and artificial intelligence (AI), the landscape is undergoing a massive transition. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

AUGUST 9, 2022

Pharma Manufacturer Solutions. GM of Manufacturer Solutions. 1 GoodRx’s partnerships with pharma manufacturers and other key stakeholders in the healthcare industry enable them to offer discounts which have helped patients fill at least 80 million prescriptions that they otherwise could not afford.

Prescription 105

Prescription Medical Patients Side effects 105

Contrarian Sales Techniques

FEBRUARY 26, 2023

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% For example, non-branded generics account for more than 40% of the total US pharmaceutical market in the United States and more than 50% in the United Kingdom.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

PM360

AUGUST 26, 2024

As cost constraints and care rationing under the transition to corporatist “value-based” care, any reduction in cost, misdiagnosis, non-targeted treatment, and unnecessary side effects must shift focus of care from reaction to prediction, and from Rx cycling to prevention. Roche expanded its collaboration with Janssen Biotech Inc.,

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

European Pharmaceutical Review

FEBRUARY 20, 2025

4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceutical manufacturers could consider shifting production closer to domestic markets to reduce exposure. Internet] Fierce Pharma. Available from: [link] The post How could tariffs impact the pharmaceutical industry?

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20